Nearly half of the women with HGSOC have HRD, while only approximately 21% of the patients carry germline or somatic BRCA1/2 loss-of-function mutations. This evidence concerns the gene BRCA1 and hypoparathyroidism-retardation-dysmorphism syndrome.